“The new updated edition of the Penta guidelines to support the use of ARVs in children is an essential contribution to paediatric patient care. Huge thanks to all those who participated in and led this work.” – Carlo Giaquinto
We are pleased to report that the 2019 Penta guidelines for first and second line antiretroviral treatment are now available. The aim of these guidelines is to provide an update to previous versions and are intended to guide antiretroviral choices for children and adolescents with perinatally acquired HIV in the European region.
The guidance will be updated at regular intervals by the Penta guidelines writing group or as significant new data or evidence becomes available.
You can download the guidelines here.